Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes

被引：0
|
作者：
Susanne M. Cabrera
Samuel Engle
Mary Kaldunski
Shuang Jia
Rhonda Geoffrey
Pippa Simpson
Aniko Szabo
Cate Speake
Carla J. Greenbaum
Yi-Guang Chen
Martin J. Hessner
机构：
[1] Children’s Research Institute of Children’s Hospital of Wisconsin,Max McGee Research Center for Juvenile Diabetes
[2] Medical College of Wisconsin,Department of Pediatrics, Section of Endocrinology
[3] Medical College of Wisconsin,Department of Pediatrics, Division of Quantitative Health Sciences
[4] Medical College of Wisconsin,Division of Biostatistics
[5] Diabetes Clinical Research Program,undefined
[6] Benaroya Research Institute,undefined
来源：
Diabetologia | 2018年 / 61卷
关键词：
Biomarker; CTLA4-Ig; Disease heterogeneity; Honeymoon; Partial remission; Therapeutic response; Type 1 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2356 / 2370
页数：14
相关论文
共 13 条
  • [1] Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes
    Cabrera, Susanne M.
    Engle, Samuel
    Kaldunski, Mary
    Jia, Shuang
    Geoffrey, Rhonda
    Simpson, Pippa
    Szabo, Aniko
    Speake, Cate
    Greenbaum, Carla J.
    Chen, Yi-Guang
    Hessner, Martin J.
    DIABETOLOGIA, 2018, 61 (11) : 2356 - 2370
  • [2] GAD treatment and insulin secretion in recent-onset type 1 diabetes
    Ludvigsson, Johnny
    Faresjo, Maria
    Hjorth, Maria
    Axelsson, Stina
    Cheramy, Mikael
    Pihl, Mikael
    Vaarala, Outi
    Forsander, Gun
    Ivarsson, Sten
    Johansson, Calle
    Lindh, Agne
    Nilsson, Nils-Osten
    Aman, Jan
    Ortqvist, Eva
    Zerhouni, Peter
    Casas, Rosaura
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (18): : 1909 - 1920
  • [3] Association of low-grade inflammation with early changes of glycaemic control, insulin sensitivity and secretion in recent-onset type 1 and type 2 diabetes
    Weber, K. S.
    Nowotny, B.
    Strassburger, K.
    Pacini, G.
    Szendroedi, J.
    Muessig, K.
    Herder, C.
    Roden, M.
    DIABETOLOGIA, 2015, 58 : S326 - S327
  • [4] GAD-treatment of children and adolescents with recent-onset type 1 diabetes preserves residual insulin secretion after 30 months
    Ludvigsson, Johnny
    Cheramy, Mikael
    Axelsson, Stina
    Pihl, Mikael
    Akerman, Linda
    Casas, Rosaura
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (05) : 405 - 414
  • [5] Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials
    Jacobsen, Laura M.
    Cuthbertson, David
    Bundy, Brian N.
    Atkinson, Mark A.
    Moore, Wayne
    Haller, Michael J.
    Russell, William E.
    Gitelman, Stephen E.
    Herold, Kevan C.
    Redondo, Maria J.
    Sims, Emily K.
    Wherrett, Diane K.
    Moran, Antoinette
    Pugliese, Alberto
    Gottlieb, Peter A.
    Sosenko, Jay M.
    Ismail, Heba M.
    DIABETES CARE, 2024, 47 (06) : 1048 - 1055
  • [6] Non-diabetic first degree relatives of type 1 diabetics vs recent-onset type 1 diabetics: insulin secretion and insulin sensitivity changes at onset of type 1 diabetes
    Milicic, T.
    Lalic, N.
    Jotic, A.
    Markovic, I.
    Lalic, K.
    Lukic, L.
    Rajkovic, N.
    Macesic, M.
    Seferovic, J.
    Stanarcic, J.
    DIABETOLOGIA, 2013, 56 : S134 - S134
  • [7] The C-peptide-glucose ratio as a marker for insulin secretion predicts future insulin treatment and glycaemia in persons with recent-onset type 2 diabetes
    von Schwartzenberg, R. Jumpertz
    Bodis, K.
    Martin, J.
    Schon, M.
    de Angelis, M. Hrabe
    Perakakis, N.
    Kabisch, S.
    Pfeiffer, A.
    Blueher, M.
    Szendroedi, J.
    Stefan, N.
    Wagner, R.
    Birkenfeld, A. L.
    Roden, M.
    Fritsche, A.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S138 - S138
  • [8] Latent autoimmune diabetes in adults vs recent-onset type 1 diabetes: differences in autoantibody levels, clinical course and residual insulin secretion capacity
    Lukic, L.
    Lalic, N. M.
    Jotic, A.
    Milicic, T.
    Zamaklar, M.
    Lalic, K.
    Rajkovic, N.
    DIABETOLOGIA, 2008, 51 : S233 - S233
  • [9] Association of the CTLA4 gene with disease severity and autoimmune activity in recent onset type 1 diabetes. Results from the hvidoere study, group on childhood diabetes
    Kaas, A
    Nielsen, LB
    Mortensen, HB
    Holl, R
    Swift, P
    Hougaard, P
    Gammeltoft, S
    Hansen, L
    DIABETES, 2005, 54 : A277 - A277
  • [10] Increased Effector Memory Insulin-Specific CD4+ T Cells Correlate With Insulin Autoantibodies in Patients With Recent-Onset Type 1 Diabetes
    Spanier, Justin A.
    Sahli, Nathanael L.
    Wilson, Joseph C.
    Martinov, Tijana
    Dileepan, Thamotharampillai
    Burrack, Adam L.
    Finger, Erik B.
    Blazar, Bruce R.
    Michels, Aaron W.
    Moran, Antoinette
    Jenkins, Marc K.
    Fife, Brian T.
    DIABETES, 2017, 66 (12) : 3051 - 3060
12